Management of Irritable Bowel Syndrome: Novel Approaches to the Pharmacology of Gut Motility
Although it is unclear to what extent irritable bowel syndrome (IBS) symptoms represent a normal perception of abnormal function or an abnormal perception of normal function, many believe that IBS constitutes the clinical expression of an underlying motility disorder, affecting primarily the mid- an...
Main Authors: | Carmelo Scarpignato, Iva Pelosini |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1999-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1999/183697 |
Similar Items
-
Irritable Bowel Syndrome: New Approaches to Its Pharmacological Management
by: Gervais Tougas
Published: (2001-01-01) -
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
by: Susanta Kumar Padhy, et al.
Published: (2015-10-01) -
Targeting the gut microbiota for the treatment of irritable bowel syndrome
by: Charles C. Herndon, et al.
Published: (2020-03-01) -
The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome
by: Yu Gu, et al.
Published: (2019-08-01) -
Role of gut pathogens in development of irritable bowel syndrome
by: Madhusudan Grover
Published: (2014-01-01)